Meng Qian, Zhu Hongwen, Li Yuanyuan, Peng Xiaotian, Wang Tianming, Huang Hui, Zhou Hu, Liu Yuejia, Ru Sujie, Wu Jiasheng, Ma Yueming
Department of Pharmacology, School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Analytical Research Center for Organic and Biological Molecules, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Front Pharmacol. 2024 Feb 26;15:1341020. doi: 10.3389/fphar.2024.1341020. eCollection 2024.
Yinchenzhufu decoction (YCZFD) is a traditional Chinese medicine formula with hepatoprotective effects. In this study, the protective effects of YCZFD against cholestatic liver fibrosis (CLF) and its underlying mechanisms were evaluated. A 3, 5-diethoxycarbonyl-1, 4-dihydro-collidine (DDC)-induced cholestatic mouse model was used to investigate the amelioration of YCZFD on CLF. Data-independent acquisition-based mass spectrometry was performed to investigate proteomic changes in the livers of mice in three groups: control, model, and model treated with high-dose YCZFD. The effects of YCZFD on the expression of key proteins were confirmed in mice and cell models. YCZFD significantly decreased the levels of serum biochemical, liver injury, and fibrosis indicators of cholestatic mice. The proteomics indicated that 460 differentially expressed proteins (DEPs) were identified among control, model, and model treated with high-dose YCZFD groups. Enrichment analyses of these DEPs revealed that YCZFD influenced multiple pathways, including PI3K-Akt, focal adhesion, ECM-receptor interaction, glutathione metabolism, and steroid biosynthesis pathways. The expression of platelet derived growth factor receptor beta (PDGFRβ), a receptor associated with the PI3K/AKT and focal adhesion pathways, was upregulated in the livers of cholestatic mice but downregulated by YCZFD. The effects of YCZFD on the expression of key proteins in the PDGFRβ/PI3K/AKT pathway were further confirmed in mice and transforming growth factor-β-induced hepatic stellate cells. We uncovered seven plant metabolites (chlorogenic acid, scoparone, isoliquiritigenin, glycyrrhetinic acid, formononetin, atractylenolide I, and benzoylaconitine) of YCZFD that may regulate PDGFRβ expression. YCZFD substantially protects against DDC-induced CLF mainly through regulating the PDGFRβ/PI3K/AKT signaling pathway.
茵陈术附汤(YCZFD)是一种具有肝脏保护作用的中药配方。在本研究中,评估了YCZFD对胆汁淤积性肝纤维化(CLF)的保护作用及其潜在机制。采用3,5 - 二乙氧基羰基 - 1,4 - 二氢可力丁(DDC)诱导的胆汁淤积小鼠模型来研究YCZFD对CLF的改善作用。进行了基于数据非依赖采集的质谱分析,以研究三组小鼠肝脏中的蛋白质组变化:对照组、模型组和高剂量YCZFD治疗的模型组。在小鼠和细胞模型中证实了YCZFD对关键蛋白表达的影响。YCZFD显著降低了胆汁淤积小鼠的血清生化指标、肝损伤指标和纤维化指标水平。蛋白质组学表明,在对照组、模型组和高剂量YCZFD治疗的模型组之间鉴定出460种差异表达蛋白(DEP)。对这些DEP的富集分析表明,YCZFD影响多种信号通路,包括PI3K - Akt、粘着斑、细胞外基质 - 受体相互作用、谷胱甘肽代谢和类固醇生物合成通路。血小板衍生生长因子受体β(PDGFRβ)是一种与PI3K/AKT和粘着斑通路相关的受体,其在胆汁淤积小鼠肝脏中的表达上调,但被YCZFD下调。在小鼠和转化生长因子 - β诱导的肝星状细胞中进一步证实了YCZFD对PDGFRβ/PI3K/AKT通路中关键蛋白表达的影响。我们发现了YCZFD的七种植物代谢产物(绿原酸、滨蒿内酯、异甘草素、甘草次酸、芒柄花素、白术内酯I和苯甲酰乌头碱)可能调节PDGFRβ的表达。YCZFD主要通过调节PDGFRβ/PI3K/AKT信号通路对DDC诱导的CLF具有显著保护作用。